Seguir
Christopher Rowland, PhD
Christopher Rowland, PhD
TG Therapeutics
Dirección de correo verificada de tgtxinc.com
Título
Citado por
Citado por
Año
Chondrogenesis of adult stem cells from adipose tissue and bone marrow: induction by growth factors and cartilage-derived matrix
BO Diekman, CR Rowland, DP Lennon, AI Caplan, F Guilak
Tissue Engineering Part A 16 (2), 523-533, 2010
3362010
The effects of crosslinking of scaffolds engineered from cartilage ECM on the chondrogenic differentiation of MSCs
CR Rowland, DP Lennon, AI Caplan, F Guilak
Biomaterials 34 (23), 5802-5812, 2013
1982013
Fabrication of anatomically-shaped cartilage constructs using decellularized cartilage-derived matrix scaffolds
CR Rowland, LA Colucci, F Guilak
Biomaterials 91, 57-72, 2016
1302016
Regulation of decellularized tissue remodeling via scaffold-mediated lentiviral delivery in anatomically-shaped osteochondral constructs
CR Rowland, KA Glass, AR Ettyreddy, CC Gloss, JRL Matthews, ...
Biomaterials 177, 161-175, 2018
702018
Meniscus-derived matrix scaffolds promote the integrative repair of meniscal defects
JC Ruprecht, TD Waanders, CR Rowland, JF Nishimuta, KA Glass, ...
Scientific reports 9 (1), 8719, 2019
372019
Factors influencing the long-term behavior of extracellular matrix-derived scaffolds for musculoskeletal soft tissue repair
CR Rowland, D Little, F Guilak
Journal of long-term effects of medical implants 22 (3), 2012
212012
Favorable outcomes for patients treated with U2 with co-morbidities or concomitant medications: A retrospective analysis of Unity-CLL phase 3 trial
JP Ibarz, W Jurczak, S Kambhampati, EL Maranda, T Wróbel, JP Sharman, ...
Blood 138, 3748, 2021
42021
Phase 2 trial of umbralisib, ublituximab, and venetoclax in patients with relapsed/refractory mantle cell lymphoma
DS Wallace, C Rowland, BT Hill, AM Baran, C Casulo, PM Reagan, ...
Leukemia & Lymphoma 64 (9), 1579-1582, 2023
12023
Response-adapted, time-limited venetoclax, umbralisib, and ublituximab for relapsed/refractory chronic lymphocytic leukemia
BT Hill, S Ma, CS Zent, AM Baran, DS Wallace, A Advani, A Winter, ...
Blood Advances 8 (2), 378-387, 2024
2024
Venetoclax based combination therapy does not overcome poor outcomes in BTKi‐refractory mantle cell lymphoma: phase 2 trial of umbralisib, ublituximab, and venetoclax
DS Wallace, C Rowland, BT Hill, AM Baran, C Casulo, PM Reagan, ...
Hematological Oncology 41, 484-486, 2023
2023
502. Biomaterial-Mediated Lentiviral Delivery of Anti-Inflammatory Genes in Cartilage-Derived Matrix Hemispheres
KA Glass, CR Rowland, AR Ettyreddy, JM Brunger, NPT Huynh, ...
Molecular Therapy 24, S199-S200, 2016
2016
Development of Cartilage-Derived Matrix Scaffolds via Crosslinking, Decellularization, and Ice-Templating
CR Rowland
Duke University, 2015
2015
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–12